Price Data


Syneron Medical Ltd. (NASDAQ: ELOS) is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint.

The Company’s technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring,  hair removal, wrinkle reduction, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela.  

Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.  The company markets, services and supports its products in 86 countries.  It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.

Additional information can be found at


Syneron Investor Presentation August 2015 - Updated
Syneron Investor Presentation August 2015 - Updated (3.8 MB)

Syneron Events
Tuesday, August 4, 2015
8:30am EDT

Investors and analysts may participate in the conference call using the following dial-in numbers: US (toll free): (877) 280-2342 International: (646) 254 3366 The conference passcode for both is...

Thursday, February 12, 2015
11:35am EST

Sarit Soccary Ben Yochanan, Vice President of Business Development and Strategy, and Brian Hayes, Vice President of Body Shaping Group, are scheduled to participate in the 2015 Leerink Global...

See calendar

print email